NCT04355832View on ClinicalTrials.gov

Glucagon-like Peptide-1 in Type 1 Diabetes

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

Glucagon-like peptide-1

Infusion of Glucagon-like peptide-1

DRUG

Placebos

Infusion of normal saline solution that will mimic Glucagon-like peptide-1

Trial Locations (1)

21201

RECRUITING

University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER